Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances
Xiaoqian Niu, Jiejian Chen, Jianqing Gao
Asian Journal of Pharmaceutical Sciences (2018) Vol. 14, Iss. 5, pp. 480-496
Open Access | Times Cited: 162

Showing 1-25 of 162 citing articles:

Evolution of blood–brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies
Liang Han, Chen Jiang
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 8, pp. 2306-2325
Open Access | Times Cited: 232
Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases
Nur Shafika Mohd Sairazi, K. N. S. Sirajudeen
Evidence-based Complementary and Alternative Medicine (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 160
Emerging Applications of Nanotechnology in Healthcare Systems: Grand Challenges and Perspectives
Sumaira Anjum, Sara Ishaque, Hijab Fatima, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 8, pp. 707-707
Open Access | Times Cited: 158
Neuroprotective Natural Products for Alzheimer’s Disease
Xin Chen, Joshua Adam Drew, Wren Berney, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1309-1309
Open Access | Times Cited: 150
Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases
Shima Masoudi Asil, Jyoti Ahlawat, Gileydis Guillama Barroso, et al.
Biomaterials Science (2020) Vol. 8, Iss. 15, pp. 4109-4128
Open Access | Times Cited: 140
New Avenues for the Treatment of Huntington’s Disease
Amy Kim, Kathryn M. Lalonde, Aaron Truesdell, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8363-8363
Open Access | Times Cited: 138
Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system
Hui Liu, Yuyan Su, Xinchi Jiang, et al.
Drug Delivery and Translational Research (2022) Vol. 13, Iss. 3, pp. 716-737
Open Access | Times Cited: 106
Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges
Md. Habibur Rahman, Johny Bajgai, Ailyn Fadriquela, et al.
Molecules (2021) Vol. 26, Iss. 17, pp. 5327-5327
Open Access | Times Cited: 103
Recent advancements of nanoparticles application in cancer and neurodegenerative disorders: At a glance
Md. Mominur Rahman, Md. Rezaul Islam, Shopnil Akash, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113305-113305
Closed Access | Times Cited: 92
Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases
Maria Inês Teixeira, Carla M. Lopes, Maria Helena Amaral, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 221, pp. 112999-112999
Open Access | Times Cited: 71
Gene therapy for CNS disorders: modalities, delivery and translational challenges
Jingjing Gao, Swetharajan Gunasekar, Ziting Xia, et al.
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 8, pp. 553-572
Closed Access | Times Cited: 19
Oxidative stress modulating nanomaterials and their biochemical roles in nanomedicine
Kapil D. Patel, Zalike Keskin‐Erdogan, Prasad Sawadkar, et al.
Nanoscale Horizons (2024) Vol. 9, Iss. 10, pp. 1630-1682
Closed Access | Times Cited: 19
Exosome-Based Delivery of miR-124 in a Huntington’s Disease Model
Soon‐Tae Lee, Wooseok Im, Jae‐Jun Ban, et al.
Journal of Movement Disorders (2017) Vol. 10, Iss. 1, pp. 45-52
Open Access | Times Cited: 136
Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders
Seyed Zachariah Moradi, Saeideh Momtaz, Zahra Bayrami, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 136
Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics
Sudip Mukherjee, Vijay Sagar Madamsetty, Dwaipayan Bhattacharya, et al.
Advanced Functional Materials (2020) Vol. 30, Iss. 35
Closed Access | Times Cited: 117
Iron oxide nanoparticles: synthesis, functionalization, and applications in diagnosis and treatment of cancer
Aldahir Alberto Hernández Hernández, Gabriel Aguirre‐Álvarez, Raquel Cariño‐Cortés, et al.
Chemical Papers (2020) Vol. 74, Iss. 11, pp. 3809-3824
Closed Access | Times Cited: 102
Nanomaterials for the treatment and diagnosis of Alzheimer's disease: An overview
Muhammad Bilal, Mahmood Barani, Fakhara Sabir, et al.
NanoImpact (2020) Vol. 20, pp. 100251-100251
Closed Access | Times Cited: 100
Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease
Jiaolong Yang, Shilin Luo, Jichun Zhang, et al.
Neurobiology of Disease (2020) Vol. 148, pp. 105218-105218
Open Access | Times Cited: 99
Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases
Maria Inês Teixeira, Carla M. Lopes, Maria Helena Amaral, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 149, pp. 192-217
Closed Access | Times Cited: 97
Biomaterials in Neurodegenerative Disorders: A Promising Therapeutic Approach
Matteo Bordoni, Eveljn Scarian, Federica Rey, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3243-3243
Open Access | Times Cited: 80
Local delivery of USC-derived exosomes harboring ANGPTL3 enhances spinal cord functional recovery after injury by promoting angiogenesis
Yong Cao, Yan Xu, Chun‐Yuan Chen, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 73
Dodging blood brain barrier with “nano” warriors: Novel strategy against ischemic stroke
Suhel Parvez, Medha Kaushik, Mubashshir Ali, et al.
Theranostics (2021) Vol. 12, Iss. 2, pp. 689-719
Open Access | Times Cited: 59
The roles of gold nanoparticles in the detection of amyloid-β peptide for Alzheimer's disease
Jiuhong Zhao, Na Xu, Xiaotong Yang, et al.
Colloids and Interface Science Communications (2022) Vol. 46, pp. 100579-100579
Open Access | Times Cited: 54
Biomimetic Lipopolysaccharide‐Free Bacterial Outer Membrane‐Functionalized Nanoparticles for Brain‐Targeted Drug Delivery
Haiyan Chen, Mengyuan Zhou, Yuteng Zeng, et al.
Advanced Science (2022) Vol. 9, Iss. 16
Open Access | Times Cited: 51
Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance
Md. Mominur Rhaman, Md. Rezaul Islam, Shopnil Akash, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top